CN115845033A - Flexible sugar-sensitive gel microneedle patch containing bubble structure and preparation method thereof - Google Patents
Flexible sugar-sensitive gel microneedle patch containing bubble structure and preparation method thereof Download PDFInfo
- Publication number
- CN115845033A CN115845033A CN202211550100.2A CN202211550100A CN115845033A CN 115845033 A CN115845033 A CN 115845033A CN 202211550100 A CN202211550100 A CN 202211550100A CN 115845033 A CN115845033 A CN 115845033A
- Authority
- CN
- China
- Prior art keywords
- microneedle
- microneedle patch
- sensitive gel
- room temperature
- sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims abstract description 78
- 102000004877 Insulin Human genes 0.000 claims abstract description 39
- 108090001061 Insulin Proteins 0.000 claims abstract description 39
- 229940125396 insulin Drugs 0.000 claims abstract description 39
- 108010039918 Polylysine Proteins 0.000 claims abstract description 33
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 11
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 11
- 239000000758 substrate Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims description 51
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 238000000502 dialysis Methods 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 20
- 239000002243 precursor Substances 0.000 claims description 19
- 239000007864 aqueous solution Substances 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- CZDWJVSOQOMYGC-UHFFFAOYSA-N 4-borono-2-fluorobenzoic acid Chemical compound OB(O)C1=CC=C(C(O)=O)C(F)=C1 CZDWJVSOQOMYGC-UHFFFAOYSA-N 0.000 claims description 9
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 7
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- -1 Polyethylene Polymers 0.000 claims description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 150000003457 sulfones Chemical class 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 239000004698 Polyethylene Substances 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 238000001308 synthesis method Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 22
- 238000000034 method Methods 0.000 abstract description 13
- 238000001035 drying Methods 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 7
- 238000006116 polymerization reaction Methods 0.000 abstract description 5
- 238000005406 washing Methods 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 3
- 239000003623 enhancer Substances 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 3
- 230000004044 response Effects 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 26
- 239000008103 glucose Substances 0.000 description 26
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 238000010254 subcutaneous injection Methods 0.000 description 5
- 239000007929 subcutaneous injection Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 235000021152 breakfast Nutrition 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000000635 electron micrograph Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 102100023915 Insulin Human genes 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开一种含气泡结构的韧性糖敏凝胶微针贴及其制备方法。微针贴由基底和在基底上呈阵列排布的微针组成,其中微针底部包含气泡。基底和微针均是由苯硼酸修饰ε‑聚赖氨酸、聚乙烯醇和胰岛素混合而成的韧性材料构成的。本发明的微针贴的强度满足刺穿皮肤的需求,同时韧性材料和气泡设计使微针在强压力下发生微针弯曲而不是微针断裂,可避免不当使用中微针断裂在人体皮肤内而造成的危害。另外,本发明采用“注模‑干燥”两步法即可获得,无需聚合、洗涤或冻融步骤,也无需添加增强剂,可避免微针贴变形和胰岛素活性损失问题,同时可降低工艺成本,利于规模化生产;还具有血糖响应性能,可根据实际血糖水平自动调节胰岛素的释放速率及释放剂量。
The invention discloses a tough sugar-sensitive gel microneedle patch containing air bubbles and a preparation method thereof. The microneedle patch consists of a substrate and microneedles arranged in an array on the substrate, wherein the bottom of the microneedles contains air bubbles. Both the substrate and the microneedles are composed of a tough material mixed with phenylboronic acid-modified ε-polylysine, polyvinyl alcohol, and insulin. The strength of the microneedle patch of the present invention meets the needs of piercing the skin. At the same time, the tough material and air bubble design make the microneedle bend under strong pressure instead of breaking the microneedle, which can prevent the microneedle from breaking in the human skin during improper use. the harm caused. In addition, the present invention can be obtained by the two-step method of "injection-drying", without polymerization, washing or freeze-thaw steps, and without adding enhancers, which can avoid the problems of microneedle patch deformation and insulin activity loss, and can reduce process costs , which is conducive to large-scale production; it also has blood sugar response performance, and can automatically adjust the release rate and release dose of insulin according to the actual blood sugar level.
Description
技术领域technical field
本发明属于功能高分子技术领域的一种凝胶微针贴及其制备方法,具体涉及一种含气泡结构的韧性糖敏凝胶微针贴及其制备方法。The invention belongs to the technical field of functional polymers, and relates to a gel microneedle patch and a preparation method thereof, in particular to a tough sugar-sensitive gel microneedle patch with a bubble structure and a preparation method thereof.
背景技术Background technique
糖尿病被认为是近年来最具挑战的公共卫生问题之一,根据国际糖尿病联盟的统计,2021年全球糖尿病患者数量高达5.37亿。从外部补充胰岛素是糖尿病治疗方案中的重要组成部分之一,目前皮下注射胰岛素是糖尿病患者补充胰岛素的常用方法。然而,皮下注射所产生的疼痛感较强,因此对患者造成的负担较大。Diabetes is considered to be one of the most challenging public health problems in recent years. According to statistics from the International Diabetes Federation, the number of diabetic patients worldwide will reach 537 million in 2021. Supplementing insulin from the outside is one of the important components in the treatment of diabetes. At present, subcutaneous injection of insulin is a common method for diabetic patients to supplement insulin. However, the subcutaneous injection causes a strong sense of pain, and thus imposes a large burden on the patient.
近来,含有胰岛素的糖敏凝胶微针贴受到研究人员的广泛关注。其原理为,将含有胰岛素的糖敏凝胶微针贴刺入人体皮肤,凝胶微针溶胀诱导胰岛素从微针内部向皮下组织扩散,并根据实际血糖水平自动释放出适宜剂量的胰岛素,从而起到降血糖效果。由于微针的长度不足以达到皮下神经所在位置,因此并不产生疼痛感。Recently, glucose-sensitive gel microneedle patches containing insulin have received extensive attention from researchers. The principle is that the glucose-sensitive gel microneedle patch containing insulin is pierced into human skin, and the swelling of the gel microneedle induces insulin to diffuse from the inside of the microneedle to the subcutaneous tissue, and automatically releases an appropriate dose of insulin according to the actual blood sugar level, thereby Have a hypoglycemic effect. Since the microneedles are not long enough to reach the subcutaneous nerve, there is no pain.
目前糖敏凝胶微针贴的技术难点在于制备工艺复杂和微针脆性大易断裂两个方面。例如,Yu等报道了“注模-聚合-洗涤-干燥”四步法制备糖敏凝胶微针贴的制备工艺,其工艺流程较长,且其中聚合步骤可影响胰岛素活性,洗涤步骤亦导致胰岛素的部分损失及微针贴变形问题;另外,所得微针贴在受较大压力时会发生断裂,断裂碎片可积聚在患者体内诱导长期安全性问题。专利CN113197838公开了“注模-冻融-干燥”三步法制备糖敏凝胶微针贴的制备工艺,其避免了聚合和洗涤步骤导致的问题,同时新增冻融步骤可强化微针的强度;然而冻融步骤耗时较长,且对工艺参数(温度、湿度、冻融次数和时间等)要求较高,因此将增加规模化生产的成本。At present, the technical difficulties of the sugar-sensitive gel microneedle patch lie in two aspects: the complicated preparation process and the brittleness of the microneedles. For example, Yu et al. reported a four-step process of "injection molding-polymerization-washing-drying" to prepare glucose-sensitive gel microneedle patches. The process flow is long, and the polymerization step can affect insulin activity, and the washing step can also cause Partial loss of insulin and deformation of the microneedle patch; in addition, the obtained microneedle patch will break when subjected to greater pressure, and the broken fragments can accumulate in the patient's body to induce long-term safety problems. Patent CN113197838 discloses a three-step process of “injection molding-freezing-thawing-drying” to prepare sugar-sensitive gel microneedle patches, which avoids the problems caused by polymerization and washing steps, and at the same time, the new freeze-thawing step can strengthen the microneedle. Strength; however, the freeze-thaw steps take a long time and require high process parameters (temperature, humidity, freeze-thaw times and time, etc.), which will increase the cost of large-scale production.
发明内容Contents of the invention
为了解决上述问题,本发明提供了一种含气泡结构的韧性糖敏凝胶微针贴及其制备方法。含气泡结构的韧性糖敏凝胶微针贴由基底和在基底上呈阵列排布的微针组成,其中微针底部包含气泡。含气泡结构的韧性糖敏凝胶微针贴是由苯硼酸修饰ε-聚赖氨酸、聚乙烯醇和胰岛素混合而成的韧性材料构成的。本发明的含气泡结构的韧性糖敏凝胶微针贴的强度满足刺穿皮肤的需求,同时韧性材料和气泡设计使微针在强压力下发生微针弯曲而不是微针断裂,可避免出现背景技术中提到微针脆性大易断裂的问题,进而消除不当使用中微针断裂在人体皮肤内而造成的危害。另外,本发明的含气泡结构的韧性糖敏凝胶微针贴采用“注模-干燥”两步法即可获得,可避免现有技术中三步甚至四步的负载制备工艺,无需聚合、洗涤或冻融步骤,也无需添加增强剂,可避免微针贴变形和胰岛素活性损失问题,同时可降低工艺成本,利于规模化生产;含气泡结构的韧性糖敏凝胶微针贴具有血糖响应性能,可根据实际血糖水平自动调节胰岛素的释放速率及释放剂量。In order to solve the above problems, the present invention provides a tough sugar-sensitive gel microneedle patch containing air bubbles and a preparation method thereof. The flexible glucose-sensitive gel microneedle patch with bubble structure is composed of a base and microneedles arranged in an array on the base, wherein the bottom of the microneedles contains bubbles. The tough sugar-sensitive gel microneedle patch with bubble structure is composed of a tough material mixed with phenylboronic acid-modified ε-polylysine, polyvinyl alcohol and insulin. The strength of the tough sugar-sensitive gel microneedle patch with bubble structure of the present invention meets the needs of piercing the skin. At the same time, the design of the tough material and bubbles makes the microneedle bend under strong pressure instead of breaking the microneedle, which can avoid the occurrence of The problem of high brittleness and easy breakage of microneedles is mentioned in the background art, so as to eliminate the harm caused by microneedle breakage in human skin during improper use. In addition, the flexible sugar-sensitive gel microneedle patch with bubble structure of the present invention can be obtained by the two-step "injection-drying" method, which can avoid the three-step or even four-step loading preparation process in the prior art, without the need for polymerization, There is no need to add enhancers during washing or freeze-thawing steps, which can avoid the deformation of the microneedle patch and the loss of insulin activity. At the same time, it can reduce the process cost and facilitate large-scale production; the tough glucose-sensitive gel microneedle patch with bubble structure has blood glucose response It can automatically adjust the release rate and release dose of insulin according to the actual blood sugar level.
本发明所采用的技术方案如下:The technical scheme adopted in the present invention is as follows:
一、一种含气泡结构的韧性糖敏凝胶微针贴1. A tough glucose-sensitive gel microneedle patch with bubble structure
所述微针贴由基底和在基底上呈阵列排布的微针组成,其中微针的底部包含气泡;所述基底和微针均是由苯硼酸修饰ε-聚赖氨酸、聚乙烯醇和胰岛素混合而成的韧性材料构成的;含气泡结构的韧性糖敏凝胶微针贴采用“注模-干燥”两步法制备而成。The microneedle patch consists of a substrate and microneedles arranged in an array on the substrate, wherein the bottom of the microneedles contains air bubbles; both the substrate and the microneedles are made of phenylboronic acid modified ε-polylysine, polyvinyl alcohol and It is made of tough materials mixed with insulin; the tough sugar-sensitive gel microneedle patch with bubble structure is prepared by two-step method of "injection-drying".
所述的微针贴的微针为四棱锥形,微针高度为0.2-1mm,微针底面边长为0.05-0.5mm;基底为圆柱体,基底高度为0.01-2mm,基底直径为0.5-5cm;微针在基底上的阵列密度为10-800针/(cm2基底)。The microneedles of the microneedle patch are in the shape of a quadrangular pyramid, the height of the microneedles is 0.2-1 mm, and the side length of the bottom surface of the microneedles is 0.05-0.5 mm; the base is a cylinder, the height of the base is 0.01-2 mm, and the diameter of the base is 0.5-0.5 mm. 5cm; the array density of the microneedles on the substrate is 10-800 needles/(cm 2 substrate).
二、苯硼酸修饰ε-聚赖氨酸的合成方法Two, the synthetic method of phenylboronic acid modified epsilon-polylysine
1)将4-羧基-3-氟苯硼酸、1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐和N-羟基丁二酰亚胺投入二甲基亚砜中,在常温下以200-600rpm的搅拌速率搅拌30-60min,得到溶液A;1) Put 4-carboxy-3-fluorophenylboronic acid, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide into dimethyl In sulfone, stir at room temperature at a stirring rate of 200-600rpm for 30-60min to obtain solution A;
2)将ε-聚赖氨酸投入水中,在常温下以200-600rpm的搅拌速率搅拌5-15min,得到溶液B;2) Put ε-polylysine into water, stir at a stirring rate of 200-600rpm at room temperature for 5-15min, and obtain solution B;
3)将溶液A和溶液B混合,在常温下以200-600rpm的搅拌速率搅拌60-600min,得到混合物C;3) Mix solution A and solution B, stir at room temperature at a stirring rate of 200-600rpm for 60-600min, and obtain mixture C;
4)将混合物C装入截留分子量为500-3500Da透析袋中,并置于水中进行透析,每隔4-12h换透析水一次,换水次数为6-10次,透析水体积为3-5升,透析完毕后,再将透析袋中的混合物冻干,得到苯硼酸修饰ε-聚赖氨酸。4) Put the mixture C into a dialysis bag with a molecular weight cut-off of 500-3500Da, and place it in water for dialysis, change the dialysis water every 4-12 hours, the number of water changes is 6-10 times, and the volume of the dialysis water is 3-5 After the dialysis is completed, the mixture in the dialysis bag is freeze-dried to obtain phenylboronic acid-modified ε-polylysine.
所述步骤1)和步骤2)中,以质量份数计,4-羧基-3-氟苯硼酸为0.07-0.72份,1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐为0.07-0.75份,N-羟基丁二酰亚胺为0.04-0.45份,二甲基亚砜为10-100份,ε-聚赖氨酸为1份,水为5-10份。In the step 1) and step 2), in parts by mass, 4-carboxy-3-fluorophenylboronic acid is 0.07-0.72 parts, 1-(3-dimethylaminopropyl)-3-ethylcarbodi Imine hydrochloride is 0.07-0.75 parts, N-hydroxysuccinimide is 0.04-0.45 parts, dimethyl sulfoxide is 10-100 parts, ε-polylysine is 1 part, water is 5- 10 servings.
所述苯硼酸修饰ε-聚赖氨酸的结构式如下:The structural formula of the phenylboronic acid modified ε-polylysine is as follows:
4-羧基-3-氟苯硼酸接枝率为y/x。The graft ratio of 4-carboxy-3-fluorophenylboronic acid is y/x.
三、一种含气泡结构的韧性糖敏凝胶微针贴的制备方法3. A preparation method of a tough sugar-sensitive gel microneedle patch with a bubble structure
1)将胰岛素加入聚乙烯醇水溶液中,在常温下以200-600rpm的搅拌速率混合搅拌10-20min,然后加入苯硼酸修饰ε-聚赖氨酸水溶液,在常温下以200-600rpm的搅拌速率继续混合搅拌30-120min,将获得的混合物记为前驱体;1) Add insulin into polyvinyl alcohol aqueous solution, mix and stir at room temperature at a stirring rate of 200-600rpm for 10-20min, then add phenylboronic acid modified ε-polylysine aqueous solution, at room temperature at room temperature at a stirring rate of 200-600rpm Continue to mix and stir for 30-120min, and record the obtained mixture as the precursor;
2)将前驱体加入到微针阴模,再将微针阴模置于压力为0.1bar的真空箱内常温保存30min,然后前驱体在干燥器中常温干燥12-24h后,得到含气泡结构的韧性糖敏凝胶微针贴。2) Add the precursor to the microneedle female mold, then place the microneedle female mold in a vacuum box with a pressure of 0.1 bar and store it at room temperature for 30 minutes, and then dry the precursor in a desiccator at room temperature for 12-24 hours to obtain a bubble-containing structure The toughness of the sugar-sensitive gel microneedle patch.
所述步骤1)中,以质量分数计,胰岛素为1份;聚乙烯醇水溶液为40-60份,质量浓度为5%-10%;苯硼酸修饰ε-聚赖氨酸水溶液为40-60份,质量浓度为5%-10%。In the step 1), in terms of mass fraction, insulin is 1 part; polyvinyl alcohol aqueous solution is 40-60 parts, and the mass concentration is 5%-10%; phenylboronic acid modified ε-polylysine aqueous solution is 40-60 parts parts, the mass concentration is 5%-10%.
本发明中含气泡结构的韧性糖敏凝胶微针贴在正常使用时具有足以刺穿皮肤的强度,可以满足透皮给药的需求。韧性糖敏凝胶微针贴的前驱体在干燥后即可自发形成微针底部的气泡结构,在强压力下气泡结构可作为微针的不稳定点发生压溃变形,从而使微针所受轴向力部分变为剪切力;含气泡结构的韧性糖敏凝胶微针贴由韧性材料构成,在气泡结构导致的剪切力作用下微针弯曲而不是微针断裂。因此同时具有气泡结构和韧性材料两个特征的含气泡结构的韧性糖敏凝胶微针贴可避免微针在实际使用中断裂在人体内,从而避免断裂的微针碎片积累在体内导致的危害,因此使用安全性好。含气泡结构的韧性糖敏凝胶微针贴内部含有苯硼酸酯键交联点和氨基,前者在血糖升高时部分断裂,促使凝胶微针网络变松散,胰岛素更容易从微针内部扩散到微针外部;后者氨基提供正电荷,与带负电荷的胰岛素产生静电相互作用,以避免胰岛素过快释放导致的低血糖问题。The tough sugar-sensitive gel microneedle patch with bubble structure in the present invention has enough strength to pierce the skin in normal use, and can meet the requirement of transdermal drug delivery. The precursor of the tough sugar-sensitive gel microneedle patch can spontaneously form the bubble structure at the bottom of the microneedle after drying. Part of the axial force becomes shear force; the tough glucose-sensitive gel microneedle patch with bubble structure is made of tough material, and the microneedle bends instead of breaking under the shear force caused by the bubble structure. Therefore, the ductile glucose-sensitive gel microneedle patch with bubble structure and the characteristics of both bubble structure and tough material can prevent the microneedles from breaking in the human body during actual use, thereby avoiding the damage caused by the accumulation of broken microneedle fragments in the body , so it is safe to use. The flexible sugar-sensitive gel microneedle patch with bubble structure contains phenylboronate bond cross-linking points and amino groups. The former partly breaks when blood sugar rises, which makes the gel microneedle network loose, and insulin is easier to pass through the microneedle. Diffusion to the outside of the microneedle; the latter amino group provides a positive charge, which creates an electrostatic interaction with the negatively charged insulin to avoid hypoglycemia problems caused by the rapid release of insulin.
本发明的有益效果:Beneficial effects of the present invention:
1.本发明采用“注模-干燥”的两步法制备工艺,取消了包括聚合、洗涤和冻融在内的多个步骤,也无需添加增强剂,可完全避免胰岛素活性或负载量损失、微针变形和长耗时工艺步骤等问题,最大程度上简化了工艺流程,并降低了物料成本;1. The present invention adopts the two-step preparation process of "injection molding-drying", which eliminates multiple steps including polymerization, washing and freeze-thawing, and does not need to add enhancers, which can completely avoid the loss of insulin activity or loading capacity, Problems such as microneedle deformation and long time-consuming process steps simplify the process to the greatest extent and reduce material costs;
2.微针底部具有气泡结构,在受强压力时气泡可作为微针的不稳定点,促使韧性微针发生弯曲而非断裂,可避免断裂碎片进入患者体内导致的使用安全性问题;2. The bottom of the microneedle has a bubble structure, and the bubble can be used as an unstable point of the microneedle under strong pressure, causing the tough microneedle to bend rather than break, which can avoid the use safety problems caused by the broken fragments entering the patient's body;
3.含气泡结构的韧性糖敏凝胶微针贴具有刺穿皮肤的性能,同时还具有血糖响应性能,可实现基于血糖水平自动调节胰岛素释放速率的功能,因此可以维持血糖稳定且免去皮下注射胰岛素的痛苦。3. The tough sugar-sensitive gel microneedle patch with bubble structure has the performance of piercing the skin, and also has blood sugar response performance, which can realize the function of automatically adjusting the insulin release rate based on blood sugar level, so it can maintain blood sugar stability and avoid subcutaneous The pain of insulin injections.
附图说明Description of drawings
图1为苯硼酸修饰ε-聚赖氨酸的核磁氢谱谱图;Fig. 1 is the proton nuclear magnetic spectrum spectrogram of phenylboronic acid modified epsilon-polylysine;
图2为含气泡结构的韧性糖敏凝胶微针贴的电镜图;Fig. 2 is the electron micrograph of the tough sugar-sensitive gel microneedle patch containing bubble structure;
图3为含气泡结构的韧性糖敏凝胶微针贴的光学照片;Fig. 3 is the optical photo of the tough sugar-sensitive gel microneedle patch containing bubble structure;
图4为含气泡结构的韧性糖敏凝胶微针贴受大压力时后的电镜图;Fig. 4 is the electron microscope picture after the tough sugar-sensitive gel microneedle with bubble structure is pasted under high pressure;
图5为含气泡结构的韧性糖敏凝胶微针贴在大鼠皮肤上的刺穿微孔照片;Fig. 5 is the piercing micropore photo of the tough sugar-sensitive gel microneedle with bubble structure attached to the rat skin;
图6为含气泡结构的韧性糖敏凝胶微针贴的体外胰岛素累积释放图;Figure 6 is the in vitro insulin cumulative release diagram of the flexible glucose-sensitive gel microneedle patch containing bubble structure;
图7为含气泡结构的韧性糖敏凝胶微针贴降血糖图。Fig. 7 is a blood sugar lowering diagram of the flexible glucose-sensitive gel microneedle patch with bubble structure.
具体实施方式Detailed ways
下面结合实施例对本发明做更详尽的说明,但本发明不局限于此,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也视为本发明的保护范围之内。本说明书中未作详细描述的内容属于本领域专业技术人员公知的现有技术。Below in conjunction with embodiment the present invention is described in more detail, but the present invention is not limited thereto, for those of ordinary skill in the art, under the premise of not departing from the principle of the present invention, some improvements and modifications can also be made, These improvements and modifications are also considered within the protection scope of the present invention. The content not described in detail in this specification belongs to the prior art known to those skilled in the art.
本发明实施例如下:Embodiments of the present invention are as follows:
实施例1:Example 1:
将0.3450g 4-羧基-3-氟苯硼酸、0.3599g 1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐和0.2161g N-羟基丁二酰亚胺投入10g二甲基亚砜中,在常温下以200rpm的搅拌速率搅拌30min,得到溶液A。将0.9998gε-聚赖氨酸投入5g水中,在常温下以600rpm的搅拌速率搅拌5min,得到溶液B。将溶液A和溶液B混合,在常温下以200rpm的搅拌速率搅拌600min,得到混合物C。将混合物C装入截留分子量为1000Da透析袋中,并置于水中进行透析,每隔8h换透析水一次,换水次数为10次,透析水体积为5升,透析完毕后,将透析袋中的混合物冻干,得到苯硼酸修饰的ε-聚赖氨酸。Put 0.3450g of 4-carboxy-3-fluorophenylboronic acid, 0.3599g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 0.2161g of N-hydroxysuccinimide into 10 g of dimethyl sulfoxide was stirred at room temperature at a stirring rate of 200 rpm for 30 min to obtain a solution A. 0.9998g ε-polylysine was put into 5g water, and stirred at room temperature at a stirring rate of 600rpm for 5min to obtain solution B. Mix solution A and solution B, and stir at room temperature at a stirring rate of 200 rpm for 600 min to obtain mixture C. Put the mixture C into a dialysis bag with a molecular weight cut-off of 1000Da, and place it in water for dialysis, change the dialysis water every 8 hours, the number of water changes is 10 times, and the volume of the dialysis water is 5 liters. The mixture was lyophilized to obtain ε-polylysine modified with phenylboronic acid.
本实施案例结果如图1所示,图1为苯硼酸修饰ε-聚赖氨酸的核磁氢谱谱图。经计算,4-羧基-3-氟苯硼酸的接枝率为0.24。The results of this implementation case are shown in Figure 1, which is the H NMR spectrum of phenylboronic acid modified ε-polylysine. After calculation, the grafting rate of 4-carboxy-3-fluorophenylboronic acid was 0.24.
实施例2:Example 2:
将0.0720g 4-羧基-3-氟苯硼酸、0.0759g 1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐和0.0452g N-羟基丁二酰亚胺投入10g二甲基亚砜中,在常温下以200rpm的搅拌速率搅拌30min,得到溶液A。将0.9995gε-聚赖氨酸投入5g水中,在常温下以600rpm的搅拌速率搅拌5min,得到溶液B。将溶液A和溶液B混合,在常温下以200rpm的搅拌速率搅拌600min,得到混合物C。将混合物C装入截留分子量为500Da透析袋中,并置于水中进行透析,每隔4h换透析水一次,换水次数为6次,透析水体积为5升,透析完毕后,将透析袋中的混合物冻干,得到苯硼酸修饰的ε-聚赖氨酸。Put 0.0720g of 4-carboxy-3-fluorophenylboronic acid, 0.0759g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 0.0452g of N-hydroxysuccinimide into 10 g of dimethyl sulfoxide was stirred at room temperature at a stirring rate of 200 rpm for 30 min to obtain a solution A. 0.9995g ε-polylysine was put into 5g water, and stirred at room temperature at a stirring rate of 600rpm for 5min to obtain solution B. Mix solution A and solution B, and stir at room temperature at a stirring rate of 200 rpm for 600 min to obtain mixture C. Put the mixture C into a dialysis bag with a molecular weight cut-off of 500 Da, and place it in water for dialysis, change the dialysis water once every 4 hours, the number of water changes is 6 times, and the volume of the dialysis water is 5 liters. The mixture was lyophilized to obtain ε-polylysine modified with phenylboronic acid.
实施例3:Example 3:
将0.7161g 4-羧基-3-氟苯硼酸、0.7452g 1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐和0.4483g N-羟基丁二酰亚胺投入100g二甲基亚砜中,在常温下以600rpm的搅拌速率搅拌60min,得到溶液A。将1.0208gε-聚赖氨酸投入10g水中,在常温下以200rpm的搅拌速率搅拌15min,得到溶液B。将溶液A和溶液B混合,在常温下以600rpm的搅拌速率搅拌60min,得到混合物C。将混合物C装入截留分子量为3500Da透析袋中,并置于水中进行透析,每隔12h换透析水一次,换水次数为6次,透析水体积为3升,透析完毕后,将透析袋中的混合物冻干,得到苯硼酸修饰的ε-聚赖氨酸。Put 0.7161g of 4-carboxy-3-fluorophenylboronic acid, 0.7452g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and 0.4483g of N-hydroxysuccinimide into 100 g of dimethyl sulfoxide was stirred at room temperature at a stirring speed of 600 rpm for 60 min to obtain a solution A. Add 1.0208g of ε-polylysine into 10g of water, stir at room temperature at a stirring rate of 200rpm for 15min, and obtain solution B. Mix solution A and solution B, and stir at room temperature at a stirring speed of 600 rpm for 60 min to obtain mixture C. Put the mixture C into a dialysis bag with a molecular weight cut-off of 3500Da, and place it in water for dialysis, change the dialysis water once every 12 hours, the number of water changes is 6 times, and the volume of the dialysis water is 3 liters. The mixture was lyophilized to obtain ε-polylysine modified with phenylboronic acid.
实施例4:Example 4:
使用实施例1中制备的苯硼酸修饰ε-聚赖氨酸。将10.1mg胰岛素加入410mg5%聚乙烯醇水溶液中并在常温下以200rpm的搅拌速率混合搅拌20min,然后加入600mg 5%苯硼酸修饰的ε-聚赖氨酸水溶液并在常温下以200rpm的搅拌速率继续混合搅拌120min,所得混合物称为前驱体。将前驱体加入到微针阴模,置于压力为0.1bar的真空箱内常温保存30min,然后前驱体在干燥器中常温干燥24h。干燥后得到含气泡结构的韧性糖敏凝胶微针贴。The ε-polylysine was modified with phenylboronic acid prepared in Example 1. Add 10.1 mg of insulin to 410 mg of 5% polyvinyl alcohol aqueous solution and mix and stir at room temperature at a stirring rate of 200 rpm for 20 min, then add 600 mg of 5% phenylboronic acid-modified ε-polylysine aqueous solution and stir at room temperature at a stirring rate of 200 rpm Continue to mix and stir for 120min, and the resulting mixture is called a precursor. The precursor was added to the female microneedle mold, placed in a vacuum box with a pressure of 0.1 bar and stored at room temperature for 30 minutes, and then the precursor was dried in a desiccator at room temperature for 24 hours. After drying, a tough glucose-sensitive gel microneedle patch with bubble structure was obtained.
本实施案例结果如图2-5所示,图2为含气泡结构的韧性糖敏凝胶微针贴的电镜图,可观察到微针贴上的微针阵列形貌一致,针尖尖锐。图3为含气泡结构的韧性糖敏凝胶微针贴的光学照片,可见微针底部均包含气泡结构。图4为含气泡结构的韧性糖敏凝胶微针贴受大压力时后的电镜图,图4的a含气泡结构的韧性糖敏凝胶微针贴受大压力后部分微针针体被压入底部气泡处,同时微针针头发生弯曲而非断裂;图4的b为现有技术的凝胶微针贴受大压力后发生断裂,产生大量裂纹。图5为含气泡结构的韧性糖敏凝胶微针贴在大鼠皮肤上的刺穿微孔照片。采用台盼蓝染色法将所刺穿的微孔染成深色,可明显看到微针成功刺穿皮肤所形成的阵列样点阵。图6为含气泡结构的韧性糖敏凝胶微针贴的体外胰岛素累积释放图。葡萄糖浓度为设计为0mg/dL(控制组)、100mg/dL(正常血糖模拟组)和400mg/dL(高血糖模拟组),释放介质设计为生理条件模拟的磷酸缓冲溶液(37℃,pH7.4)。随葡萄糖浓度升高,含气泡结构的韧性糖敏凝胶微针贴的胰岛素释放量上升,即,含气泡结构的韧性糖敏凝胶微针贴具有葡萄糖响应的胰岛素释放性能,这一性能有利于在高血糖状态下快速释放胰岛素以快速降低血糖,并在正常血糖状态下少释放胰岛素以避免产生低血糖。图7为含气泡结构的韧性糖敏凝胶微针贴降血糖图。对糖尿病大鼠分别进行皮下注射胰岛素(INS组)或施用含气泡结构的韧性糖敏凝胶微针贴(GR-MNP组)。在前日19:00(-13h)禁食至当日8:00(0h)禁食,以模拟糖尿病患者晚餐至早餐间无进食的行为。然后当日8:00(0h)给予一餐食物模拟早餐,当日9:00(1h)分别进行上述两种治疗。皮下注射胰岛素后血糖快速从高血糖(高于200mg/dL)恢复至正常血糖范围(50-200mg/dL),然后在当日12:00(4h)第二餐,即模拟午餐后血糖升至高血糖,这意味着糖尿病患者需要每日注射胰岛素2-4次才能应对一日三餐的生活模式。相比而言,施用含气泡结构的韧性糖敏凝胶微针贴在模拟午餐后血糖仍不上升,至当日17:00(9h)模拟晚餐时血糖稍有上升,至次日8:00(24h)一直保持在正常血糖。次日8:00(24h)后进行模拟早餐,血糖上升。这表明施用含气泡结构的韧性糖敏凝胶微针贴可应对模拟的一日三餐模式下的血糖变化,远优于目前常用的皮下注射胰岛素这一治疗方案。The results of this implementation case are shown in Figures 2-5. Figure 2 is the electron microscope image of the tough sugar-sensitive gel microneedle patch with bubble structure. It can be observed that the microneedle arrays on the microneedle patch have the same appearance and sharp needle tips. Figure 3 is an optical photo of the tough glucose-sensitive gel microneedle patch with bubble structure. It can be seen that the bottom of the microneedle contains bubble structure. Figure 4 is the electron micrograph of the tough sugar-sensitive gel microneedle with bubble structure when it is subjected to high pressure, and part of the microneedle body is covered with the tough sugar-sensitive gel microneedle with bubble structure in Figure 4a after being subjected to high pressure Press into the air bubble at the bottom, and at the same time, the microneedle needle bends instead of breaking; Figure 4 b shows that the gel microneedle sticking of the prior art breaks after being subjected to high pressure, resulting in a large number of cracks. Fig. 5 is a photo of piercing micropores of tough sugar-sensitive gel microneedles with air bubble structure pasted on rat skin. The punctured micropores were dyed dark by trypan blue staining, and the array-like lattice formed by the microneedles successfully piercing the skin can be clearly seen. Fig. 6 is a diagram of the cumulative release of insulin in vitro of the flexible glucose-sensitive gel microneedle patch with bubble structure. The glucose concentration was designed to be 0mg/dL (control group), 100mg/dL (normal blood sugar simulation group) and 400mg/dL (hyperglycemia simulation group), and the release medium was designed to be a phosphate buffer solution (37°C, pH7. 4). With the increase of glucose concentration, the release of insulin from the flexible glucose-sensitive gel microneedle patch with bubble structure increases, that is, the flexible glucose-sensitive gel microneedle patch with bubble structure has glucose-responsive insulin release performance, which has It is beneficial to release insulin quickly in the state of hyperglycemia to quickly reduce blood sugar, and release less insulin in the state of normal blood sugar to avoid hypoglycemia. Fig. 7 is a blood sugar lowering diagram of the flexible glucose-sensitive gel microneedle patch with bubble structure. Diabetic rats were given subcutaneous injection of insulin (INS group) or the application of flexible glucose-sensitive gel microneedle patch with air bubble structure (GR-MNP group). Fast from 19:00 (-13h) of the previous day to 8:00 (0h) of the same day to simulate the behavior of diabetic patients without eating between dinner and breakfast. Then at 8:00 (0h) on the same day, a food simulated breakfast was given, and at 9:00 (1h) on the same day, the above two treatments were performed respectively. After subcutaneous injection of insulin, the blood sugar quickly returns from hyperglycemia (higher than 200mg/dL) to normal blood sugar range (50-200mg/dL), and then the second meal at 12:00 (4h) on the same day, that is, the blood sugar rises to hyperglycemia after simulated lunch , which means that diabetics need to inject insulin 2-4 times a day to cope with the life pattern of three meals a day. In contrast, the application of the flexible glucose-sensitive gel microneedle patch with air bubble structure did not increase blood sugar after simulating lunch, and the blood sugar increased slightly when simulating dinner at 17:00 (9h) of the same day, and then at 8:00 ( 24h) has been maintained in normal blood sugar. The simulated breakfast was performed after 8:00 (24h) the next day, and the blood sugar rose. This shows that the application of flexible glucose-sensitive gel microneedles with bubble structure can cope with the blood sugar changes in the simulated three meals a day mode, which is far superior to the current commonly used subcutaneous injection of insulin treatment.
实施例5:Example 5:
使用实施例1中制备的苯硼酸修饰ε-聚赖氨酸。将10.0mg胰岛素加入590mg10%聚乙烯醇水溶液中并在常温下以600rpm的搅拌速率混合搅拌10min,然后加入400mg 10%苯硼酸修饰的ε-聚赖氨酸水溶液并在常温下以600rpm的搅拌速率继续混合搅拌30min,所得混合物称为前驱体。将前驱体加入到微针阴模,置于压力为0.1bar的真空箱内常温保存30min,然后前驱体在干燥器中常温干燥24h。干燥后得到含气泡结构的韧性糖敏凝胶微针贴。The ε-polylysine was modified with phenylboronic acid prepared in Example 1. Add 10.0 mg of insulin to 590 mg of 10% polyvinyl alcohol aqueous solution and mix and stir at room temperature at a stirring rate of 600 rpm for 10 min, then add 400 mg of 10% phenylboronic acid-modified ε-polylysine aqueous solution and at room temperature at a stirring rate of 600 rpm Continue to mix and stir for 30 minutes, and the resulting mixture is called a precursor. The precursor was added to the female microneedle mold, placed in a vacuum box with a pressure of 0.1 bar and stored at room temperature for 30 minutes, and then the precursor was dried in a desiccator at room temperature for 24 hours. After drying, a tough glucose-sensitive gel microneedle patch with bubble structure was obtained.
实施例6:Embodiment 6:
使用实施例2中制备的苯硼酸修饰ε-聚赖氨酸。将10.5mg胰岛素加入500mg10%聚乙烯醇水溶液中并在常温下以600rpm的搅拌速率混合搅拌10min,然后加入500mg 10%苯硼酸修饰的ε-聚赖氨酸水溶液并在常温下以600rpm的搅拌速率继续混合搅拌30min,所得混合物称为前驱体。将前驱体加入到微针阴模,置于压力为0.1bar的真空箱内常温保存30min,然后前驱体在干燥器中常温干燥24h。干燥后得到含气泡结构的韧性糖敏凝胶微针贴。The ε-polylysine was modified with phenylboronic acid prepared in Example 2. Add 10.5 mg of insulin to 500 mg of 10% polyvinyl alcohol aqueous solution and mix and stir at room temperature at a stirring rate of 600 rpm for 10 min, then add 500 mg of 10% phenylboronic acid-modified ε-polylysine aqueous solution and at room temperature at a stirring rate of 600 rpm Continue to mix and stir for 30 minutes, and the resulting mixture is called a precursor. The precursor was added to the female microneedle mold, placed in a vacuum box with a pressure of 0.1 bar and stored at room temperature for 30 minutes, and then the precursor was dried in a desiccator at room temperature for 24 hours. After drying, a tough glucose-sensitive gel microneedle patch with bubble structure was obtained.
实施例7:Embodiment 7:
使用实施例3中制备的苯硼酸修饰ε-聚赖氨酸。将10.0mg胰岛素加入400mg10%聚乙烯醇水溶液中并在常温下以600rpm的搅拌速率混合搅拌10min,然后加入600mg 10%苯硼酸修饰的ε-聚赖氨酸水溶液并在常温下以600rpm的搅拌速率继续混合搅拌30min,所得混合物称为前驱体。将前驱体加入到微针阴模,置于压力为0.1bar的真空箱内常温保存30min,然后前驱体在干燥器中常温干燥12h。干燥后得到含气泡结构的韧性糖敏凝胶微针贴。The ε-polylysine was modified with phenylboronic acid prepared in Example 3. Add 10.0 mg of insulin to 400 mg of 10% polyvinyl alcohol aqueous solution and mix and stir at room temperature at a stirring rate of 600 rpm for 10 min, then add 600 mg of 10% phenylboronic acid-modified ε-polylysine aqueous solution and stir at room temperature at a stirring rate of 600 rpm Continue to mix and stir for 30 minutes, and the resulting mixture is called a precursor. The precursor was added to the microneedle female mold, placed in a vacuum box with a pressure of 0.1 bar and stored at room temperature for 30 minutes, and then the precursor was dried in a desiccator at room temperature for 12 hours. After drying, a tough glucose-sensitive gel microneedle patch with bubble structure was obtained.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211550100.2A CN115845033A (en) | 2022-12-05 | 2022-12-05 | Flexible sugar-sensitive gel microneedle patch containing bubble structure and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211550100.2A CN115845033A (en) | 2022-12-05 | 2022-12-05 | Flexible sugar-sensitive gel microneedle patch containing bubble structure and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115845033A true CN115845033A (en) | 2023-03-28 |
Family
ID=85669983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211550100.2A Pending CN115845033A (en) | 2022-12-05 | 2022-12-05 | Flexible sugar-sensitive gel microneedle patch containing bubble structure and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115845033A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116392501A (en) * | 2023-04-28 | 2023-07-07 | 河南大学 | A drug-loaded hydrogel with glucose responsiveness and its preparation method and application |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010233674A (en) * | 2009-03-30 | 2010-10-21 | Fujifilm Corp | Microneedle sheet, method for using the same, and method for manufacturing the same |
| CN108837299A (en) * | 2018-07-18 | 2018-11-20 | 武汉大学 | A kind of intelligence adjusts the microneedle patch and preparation method thereof of blood glucose |
| CN109675185A (en) * | 2019-01-02 | 2019-04-26 | 浙江大学 | Quick microneedle patch of a kind of phenyl boric acid water-setting matrix sugar and preparation method thereof |
| US20200238065A1 (en) * | 2017-10-11 | 2020-07-30 | Georgia Tech Research Corporation | Separable microneedle arrays for sustained release of drug |
| CN112315895A (en) * | 2020-10-27 | 2021-02-05 | 浙江大学 | Copolymer-based glucose-sensitive microneedle patch containing 3-acrylamidophenylboronic acid |
| US20210052822A1 (en) * | 2018-03-22 | 2021-02-25 | National University Corporation Tokyo Medical And Dental University | Glucose responsive composite gel composition, method for producing same, insulin delivery microneedle including said glucose responsive composite gel composition, and production method thereof |
| CN113197838A (en) * | 2021-03-31 | 2021-08-03 | 浙江大学 | Enzyme-free glucose-sensitive microneedle patch and mild preparation method thereof |
| CN113230388A (en) * | 2021-03-31 | 2021-08-10 | 浙江大学 | Microneedle patch containing insulin-loaded phenylboronic acid group epsilon-polylysine and preparation method thereof |
-
2022
- 2022-12-05 CN CN202211550100.2A patent/CN115845033A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010233674A (en) * | 2009-03-30 | 2010-10-21 | Fujifilm Corp | Microneedle sheet, method for using the same, and method for manufacturing the same |
| US20200238065A1 (en) * | 2017-10-11 | 2020-07-30 | Georgia Tech Research Corporation | Separable microneedle arrays for sustained release of drug |
| US20210052822A1 (en) * | 2018-03-22 | 2021-02-25 | National University Corporation Tokyo Medical And Dental University | Glucose responsive composite gel composition, method for producing same, insulin delivery microneedle including said glucose responsive composite gel composition, and production method thereof |
| CN108837299A (en) * | 2018-07-18 | 2018-11-20 | 武汉大学 | A kind of intelligence adjusts the microneedle patch and preparation method thereof of blood glucose |
| CN109675185A (en) * | 2019-01-02 | 2019-04-26 | 浙江大学 | Quick microneedle patch of a kind of phenyl boric acid water-setting matrix sugar and preparation method thereof |
| CN112315895A (en) * | 2020-10-27 | 2021-02-05 | 浙江大学 | Copolymer-based glucose-sensitive microneedle patch containing 3-acrylamidophenylboronic acid |
| CN113197838A (en) * | 2021-03-31 | 2021-08-03 | 浙江大学 | Enzyme-free glucose-sensitive microneedle patch and mild preparation method thereof |
| CN113230388A (en) * | 2021-03-31 | 2021-08-10 | 浙江大学 | Microneedle patch containing insulin-loaded phenylboronic acid group epsilon-polylysine and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| CHU L Y等: "Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: bubble and pedestal microneedle designs", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 99, no. 10, 5 April 2010 (2010-04-05), pages 4230 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116392501A (en) * | 2023-04-28 | 2023-07-07 | 河南大学 | A drug-loaded hydrogel with glucose responsiveness and its preparation method and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108837299B (en) | Microneedle patch for intelligently regulating blood sugar and preparation method thereof | |
| CN113230388A (en) | Microneedle patch containing insulin-loaded phenylboronic acid group epsilon-polylysine and preparation method thereof | |
| Liu et al. | Fabrication of rapidly separable microneedles for transdermal delivery of metformin on diabetic rats | |
| CN107349175A (en) | A kind of microneedle patch for loading fatty brown stain agent and preparation method thereof | |
| CN109364017A (en) | Rapid separation type soluble microneedle and preparation method thereof | |
| CN113197838B (en) | Enzyme-free glucose-sensitive microneedle patch and mild preparation method thereof | |
| CN110812688A (en) | A kind of microneedle for transdermal administration and preparation method thereof | |
| CN114146048B (en) | Needle and medicine integrated hydrogel microneedle | |
| CN115154883A (en) | Hydrogel microneedle with replaceable drug-loaded reservoir and preparation method thereof | |
| CN108392729A (en) | A kind of cross-linked-hyaluronic acid micropin of grafting drug | |
| Zong et al. | Glucose-responsive insulin microneedle patch based on phenylboronic acid for 1 diabetes treatment | |
| CN115317437B (en) | A kind of insulin delivery microneedle based on bilirubin nanomaterial and preparation method thereof | |
| CN115845033A (en) | Flexible sugar-sensitive gel microneedle patch containing bubble structure and preparation method thereof | |
| CN108653198A (en) | It is a kind of can cutaneous penetration hydrogel and its preparation method and application | |
| CN114099414A (en) | Microneedle capable of controllably and slowly releasing medicine and preparation method thereof | |
| CN113209028A (en) | Insulin-loaded glucose-sensitive phenylboronic acid group epsilon-polylysine particles and preparation method thereof | |
| CN114632145B (en) | Insulin-loaded phenylboronic acid/fatty acid double-modified epsilon-polylysine particles and preparation method thereof | |
| Jiang et al. | Thermosensitive microneedles capable of on demand insulin release for precise diabetes treatment | |
| CN113603826B (en) | A kind of preparation method of acryloylglycinamide-phenylboronic acid-based sugar-sensitive microneedle | |
| CN115869241A (en) | Core-shell structure sugar-sensitive microneedle patch based on cross-linked density variable sugar-sensitive membrane and preparation method thereof | |
| CN110840823A (en) | A kind of transfersome composite autolyzed microneedle and preparation method thereof | |
| CN118845606A (en) | A preparation method of hyaluronic acid-based gold cluster soluble microneedle and the obtained product, and application of the obtained product in antigen delivery | |
| CN113797156B (en) | A kind of hydrogel microneedle and preparation method thereof | |
| Wang et al. | A customized partitioned microneedle array based on functionalized glycol chitosan for prolonged blood glucose regulation and prevention of diabetic neuropathy | |
| CN116531312A (en) | Effervescent microneedle for deep drug release to skin and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |